|
"liu c j"的相关文件
显示项目 1096-1120 / 1268 (共51页)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Implications of hepatitis B virus genomic variations on treatment outcomes
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Metabolic syndrome on top of chronic hepatitis B: The more, the worse?
|
Chang, L.-C.;Chung, C.-S.;Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:39Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu, C.-S.; Wang, C.-C.;Wang, P.-C.; Lin, H.H.; Tseng, T.-C.; Chen, C.-H.; Su, W.-C.; Liu, C.-J.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Hsu, S.-J.;Lin, J.-W.;Chen, S.-I.;Hung, P.-H.;Tsai, H.-B.;Lai, M.-Y.;Chen, P.-J.;Chen, J.-H.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:10:15Z |
Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles
|
Chen, W.-C.; Lai, S.-F.; Liu, C.-J.; Wang, C.-L.; Wang, C.-H.; Chen, H.-H.; Hua, T.-E.; Cheng, Y.-Y.; Wu, M.K.; Hwu, Y.; Yang, C.-S.; Margaritondo, G.; Huang, F.-K.; WEN-CHANG CHEN et al. |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng, T.-C.;Liu, C.-J.;Wang, C.-C.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:00:57Z |
A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer
|
Liu, C.J.; Hsiung, P.C.; Chang, K.J.; Liu, Y.F.; Wang, K.C.; Hsiao, F.H.; Ng, S.M.; Chan, Cecilia L.W.;;Liu, Chun-Ju;Hsiung, Ping-Chuan;Chang, King-Jen;Liu, Yu-Fen;Wang, Kuo-Chang;Hsiao, Fei-Hsiu;Ng, Siu-Man;Chan, Cecilia Lw; PING-CHUAN HSIUNG; Liu, Chun-Ju; Liu, C.J.; Liu, C.J.; Hsiung, P.C.; Hsiung, Ping-Chuan; FEI-HSIU HSIAO; Hsiung, P.C.; Chang, King-Jen; Chang, K.J.; Liu, Y.F.; Liu, Y.F.; Liu, Yu-Fen; Wang, Kuo-Chang; Wang, K.C.; Hsiao, Fei-Hsiu; Hsiao, F.H.; Ng, S.M.; Ng, Siu-Man; Chan, Cecilia L.W.; Chan, Cecilia LW |
| 臺大學術典藏 |
2018-09-10T06:59:26Z |
Saddle-shaped dioxo-ruthenium(VI) and -osmium(VI) 2,3,5,7,8,10,12,13,15,17,18,20-dodecaphenylporphyrin (H2dpp) complexes. Synthesis, spectral characterisation and alkene oxidation by [RuVI(dpp)O2]
|
Liu, C.-J.;Yu, W.-Y.;Peng, S.-M.;Mak, T.C.W.;Che, C.-M.; Liu, C.-J.; Yu, W.-Y.; Peng, S.-M.; Mak, T.C.W.; Che, C.-M.; SHIE-MING PENG |
显示项目 1096-1120 / 1268 (共51页)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每页显示[10|25|50]项目
|
